Gordon Hager (Q143046): Difference between revisions
From geokb
(Created a new Item: Person record added from ORCID registry based on ORCID ID found as author/contributor to USGS publication) |
(Changed label, description and/or aliases in en, and other parts: updated description crafted from ORCID affiliation information) |
||||||||||||||
(4 intermediate revisions by the same user not shown) | |||||||||||||||
description / en | description / en | ||||||||||||||
Chief with Lab of Receptor Biology and Gene Expression at National Cancer Institute | |||||||||||||||
Property / instance of: person / reference | |||||||||||||||
Property / ORCID iD: 0000-0002-9300-5331 / reference | |||||||||||||||
Property / OpenAlex ID | |||||||||||||||
Property / OpenAlex ID: A5023528108 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / OpenAlex ID: A5023528108 / qualifier | |||||||||||||||
last update: 26 August 2024
| |||||||||||||||
Property / OpenAlex ID: A5023528108 / qualifier | |||||||||||||||
retrieved: 29 August 2024
| |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Regulation of Chromatin Structure and Function / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Regulation of Chromatin Structure and Function / qualifier | |||||||||||||||
last update: 26 August 2024
| |||||||||||||||
Property / knows about: Regulation of Chromatin Structure and Function / qualifier | |||||||||||||||
prevalence: 128
| |||||||||||||||
Property / knows about: Regulation of Chromatin Structure and Function / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Mechanisms of Estrogen Receptor Signaling / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Mechanisms of Estrogen Receptor Signaling / qualifier | |||||||||||||||
last update: 26 August 2024
| |||||||||||||||
Property / knows about: Mechanisms of Estrogen Receptor Signaling / qualifier | |||||||||||||||
prevalence: 114
| |||||||||||||||
Property / knows about: Mechanisms of Estrogen Receptor Signaling / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Regulation of RNA Processing and Function / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Regulation of RNA Processing and Function / qualifier | |||||||||||||||
last update: 26 August 2024
| |||||||||||||||
Property / knows about: Regulation of RNA Processing and Function / qualifier | |||||||||||||||
prevalence: 71
| |||||||||||||||
Property / knows about: Regulation of RNA Processing and Function / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Small Cell Lung Cancer / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Small Cell Lung Cancer / qualifier | |||||||||||||||
last update: 26 August 2024
| |||||||||||||||
Property / knows about: Small Cell Lung Cancer / qualifier | |||||||||||||||
prevalence: 66
| |||||||||||||||
Property / knows about: Small Cell Lung Cancer / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Genomic Landscape of Cancer and Mutational Signatures / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Genomic Landscape of Cancer and Mutational Signatures / qualifier | |||||||||||||||
last update: 26 August 2024
| |||||||||||||||
Property / knows about: Genomic Landscape of Cancer and Mutational Signatures / qualifier | |||||||||||||||
prevalence: 49
| |||||||||||||||
Property / knows about: Genomic Landscape of Cancer and Mutational Signatures / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: RNA Methylation and Modification in Gene Expression / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: RNA Methylation and Modification in Gene Expression / qualifier | |||||||||||||||
last update: 26 August 2024
| |||||||||||||||
Property / knows about: RNA Methylation and Modification in Gene Expression / qualifier | |||||||||||||||
prevalence: 49
| |||||||||||||||
Property / knows about: RNA Methylation and Modification in Gene Expression / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Advancements in Lung Cancer Research / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Advancements in Lung Cancer Research / qualifier | |||||||||||||||
last update: 26 August 2024
| |||||||||||||||
Property / knows about: Advancements in Lung Cancer Research / qualifier | |||||||||||||||
prevalence: 41
| |||||||||||||||
Property / knows about: Advancements in Lung Cancer Research / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: NF-?B Signaling in Inflammation and Cancer / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: NF-?B Signaling in Inflammation and Cancer / qualifier | |||||||||||||||
last update: 26 August 2024
| |||||||||||||||
Property / knows about: NF-?B Signaling in Inflammation and Cancer / qualifier | |||||||||||||||
prevalence: 39
| |||||||||||||||
Property / knows about: NF-?B Signaling in Inflammation and Cancer / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Ribosome Structure and Translation Mechanisms / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Ribosome Structure and Translation Mechanisms / qualifier | |||||||||||||||
last update: 26 August 2024
| |||||||||||||||
Property / knows about: Ribosome Structure and Translation Mechanisms / qualifier | |||||||||||||||
prevalence: 35
| |||||||||||||||
Property / knows about: Ribosome Structure and Translation Mechanisms / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Epigenetic Modifications and Their Functional Implications / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Epigenetic Modifications and Their Functional Implications / qualifier | |||||||||||||||
last update: 26 August 2024
| |||||||||||||||
Property / knows about: Epigenetic Modifications and Their Functional Implications / qualifier | |||||||||||||||
prevalence: 27
| |||||||||||||||
Property / knows about: Epigenetic Modifications and Their Functional Implications / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Mechanisms and Applications of RNA Interference / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Mechanisms and Applications of RNA Interference / qualifier | |||||||||||||||
last update: 26 August 2024
| |||||||||||||||
Property / knows about: Mechanisms and Applications of RNA Interference / qualifier | |||||||||||||||
prevalence: 26
| |||||||||||||||
Property / knows about: Mechanisms and Applications of RNA Interference / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Innate Immunity to Viral Infection / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Innate Immunity to Viral Infection / qualifier | |||||||||||||||
last update: 26 August 2024
| |||||||||||||||
Property / knows about: Innate Immunity to Viral Infection / qualifier | |||||||||||||||
prevalence: 25
| |||||||||||||||
Property / knows about: Innate Immunity to Viral Infection / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Role of STAT3 in Cancer Inflammation and Immunity / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Role of STAT3 in Cancer Inflammation and Immunity / qualifier | |||||||||||||||
last update: 26 August 2024
| |||||||||||||||
Property / knows about: Role of STAT3 in Cancer Inflammation and Immunity / qualifier | |||||||||||||||
prevalence: 24
| |||||||||||||||
Property / knows about: Role of STAT3 in Cancer Inflammation and Immunity / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Gene Therapy Techniques and Applications / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Gene Therapy Techniques and Applications / qualifier | |||||||||||||||
last update: 26 August 2024
| |||||||||||||||
Property / knows about: Gene Therapy Techniques and Applications / qualifier | |||||||||||||||
prevalence: 24
| |||||||||||||||
Property / knows about: Gene Therapy Techniques and Applications / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Fluorescence Microscopy Techniques / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Fluorescence Microscopy Techniques / qualifier | |||||||||||||||
last update: 26 August 2024
| |||||||||||||||
Property / knows about: Fluorescence Microscopy Techniques / qualifier | |||||||||||||||
prevalence: 20
| |||||||||||||||
Property / knows about: Fluorescence Microscopy Techniques / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: G-Quadruplex DNA Structures and Functions / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: G-Quadruplex DNA Structures and Functions / qualifier | |||||||||||||||
last update: 26 August 2024
| |||||||||||||||
Property / knows about: G-Quadruplex DNA Structures and Functions / qualifier | |||||||||||||||
prevalence: 18
| |||||||||||||||
Property / knows about: G-Quadruplex DNA Structures and Functions / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Immunobiology of Dendritic Cells / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Immunobiology of Dendritic Cells / qualifier | |||||||||||||||
last update: 26 August 2024
| |||||||||||||||
Property / knows about: Immunobiology of Dendritic Cells / qualifier | |||||||||||||||
prevalence: 16
| |||||||||||||||
Property / knows about: Immunobiology of Dendritic Cells / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Protein Arginine Methylation in Mammals / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Protein Arginine Methylation in Mammals / qualifier | |||||||||||||||
last update: 26 August 2024
| |||||||||||||||
Property / knows about: Protein Arginine Methylation in Mammals / qualifier | |||||||||||||||
prevalence: 15
| |||||||||||||||
Property / knows about: Protein Arginine Methylation in Mammals / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Targeted Protein Degradation in Biomedical Research / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Targeted Protein Degradation in Biomedical Research / qualifier | |||||||||||||||
last update: 26 August 2024
| |||||||||||||||
Property / knows about: Targeted Protein Degradation in Biomedical Research / qualifier | |||||||||||||||
prevalence: 14
| |||||||||||||||
Property / knows about: Targeted Protein Degradation in Biomedical Research / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Endocrine Disruption by Chemical Exposure / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Endocrine Disruption by Chemical Exposure / qualifier | |||||||||||||||
last update: 26 August 2024
| |||||||||||||||
Property / knows about: Endocrine Disruption by Chemical Exposure / qualifier | |||||||||||||||
prevalence: 13
| |||||||||||||||
Property / knows about: Endocrine Disruption by Chemical Exposure / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Role of Retinoic Acid in Biological Processes / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Role of Retinoic Acid in Biological Processes / qualifier | |||||||||||||||
last update: 26 August 2024
| |||||||||||||||
Property / knows about: Role of Retinoic Acid in Biological Processes / qualifier | |||||||||||||||
prevalence: 13
| |||||||||||||||
Property / knows about: Role of Retinoic Acid in Biological Processes / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Management of Primary Aldosteronism / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Management of Primary Aldosteronism / qualifier | |||||||||||||||
last update: 26 August 2024
| |||||||||||||||
Property / knows about: Management of Primary Aldosteronism / qualifier | |||||||||||||||
prevalence: 13
| |||||||||||||||
Property / knows about: Management of Primary Aldosteronism / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Regulatory T Cell Development and Function / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Regulatory T Cell Development and Function / qualifier | |||||||||||||||
last update: 26 August 2024
| |||||||||||||||
Property / knows about: Regulatory T Cell Development and Function / qualifier | |||||||||||||||
prevalence: 12
| |||||||||||||||
Property / knows about: Regulatory T Cell Development and Function / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Chromatin Remodeling in Cancer and Development / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Chromatin Remodeling in Cancer and Development / qualifier | |||||||||||||||
last update: 26 August 2024
| |||||||||||||||
Property / knows about: Chromatin Remodeling in Cancer and Development / qualifier | |||||||||||||||
prevalence: 11
| |||||||||||||||
Property / knows about: Chromatin Remodeling in Cancer and Development / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Immunological Mechanisms in Pregnancy and Fetal-Maternal Interface / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Immunological Mechanisms in Pregnancy and Fetal-Maternal Interface / qualifier | |||||||||||||||
last update: 26 August 2024
| |||||||||||||||
Property / knows about: Immunological Mechanisms in Pregnancy and Fetal-Maternal Interface / qualifier | |||||||||||||||
prevalence: 11
| |||||||||||||||
Property / knows about: Immunological Mechanisms in Pregnancy and Fetal-Maternal Interface / reference | |||||||||||||||
Property / employer | |||||||||||||||
Property / employer: Gene Therapy Laboratory / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / employer: Gene Therapy Laboratory / qualifier | |||||||||||||||
point in time: 2024
| |||||||||||||||
Property / employer: Gene Therapy Laboratory / reference | |||||||||||||||
Latest revision as of 23:06, 22 September 2024
Chief with Lab of Receptor Biology and Gene Expression at National Cancer Institute
Language | Label | Description | Also known as |
---|---|---|---|
English | Gordon Hager |
Chief with Lab of Receptor Biology and Gene Expression at National Cancer Institute |
Statements
26 August 2024
128
1 reference
26 August 2024
114
1 reference
26 August 2024
71
1 reference
26 August 2024
66
1 reference
26 August 2024
49
1 reference
26 August 2024
49
1 reference
26 August 2024
41
1 reference
26 August 2024
39
1 reference
26 August 2024
35
1 reference
26 August 2024
27
1 reference
26 August 2024
26
1 reference
26 August 2024
25
1 reference
26 August 2024
24
1 reference
26 August 2024
24
1 reference
26 August 2024
20
1 reference
26 August 2024
18
1 reference
26 August 2024
16
1 reference
26 August 2024
15
1 reference
26 August 2024
14
1 reference
26 August 2024
13
1 reference
26 August 2024
13
1 reference
26 August 2024
13
1 reference
26 August 2024
12
1 reference
26 August 2024
11
1 reference
26 August 2024
11
1 reference